Three-year clinical outcomes of a fractional flow reserve-guided percutaneous coronary intervention (PCI) strategy: A comparison of nicorandil and ATP

Background: Nicorandil is used to induce hyperemia when measuring fractional flow reserve (FFR). However, it is unknown whether the clinical outcome of patients assessed using nicorandil is similar to that of patients assessed using adenosine triphosphatase (ATP). We aimed to compare the clinical ou...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yuki Numajiri, Daisuke Wada, Yuki Ishii, Yuka Tanizaki, Yosuke Takei, Hiromoto Sone, Kazuma Tashiro, Takuya Mizukami, Tokutada Sato, Takaaki Matsuyama, Hiroshi Suzuki, Hiroyoshi Mori
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-08-01
Col·lecció:	International Journal of Cardiology: Heart & Vasculature
Matèries:	Nicorandil FFR Hyperemia
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2352906725001113
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!